Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/25/2012US8338412 Inhibitors of P38
12/25/2012US8338411 Compounds
12/25/2012US8338410 Neuroprotective compounds and pharmaceutical compositions comprising them
12/25/2012US8338408 Tetracyclic compounds
12/25/2012US8338407 Fused aminodihydrothiazine derivatives
12/25/2012US8338406 Benzodiazepine compound and pharmaceutical composition
12/25/2012US8338405 Therapeutic piperazines
12/25/2012US8338404 Composition and method for reducing allergen
12/25/2012US8338403 Drug for improving hyperglycemia
12/25/2012US8338402 Scaffold
12/25/2012US8338401 Coumarin-amide derivatives and its preparation, said drug composition and its use
12/25/2012US8338400 Methods and apparatus for transdermal or transmucosal application of testosterone
12/25/2012US8338399 Use of DHEA derivatives for enhancing physical performance
12/25/2012US8338398 Composition and method of treating hearing loss
12/25/2012US8338397 Composition and method of treating side effects from antibiotic treatment
12/25/2012US8338396 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
12/25/2012US8338395 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
12/25/2012US8338394 Methods for treating metabolic diseases
12/25/2012US8338393 Combination dosage forms and therapies for supporting bone health
12/25/2012US8338392 MicroRNA modulators and method for identifying and using the same
12/25/2012US8338391 Phosphine-borane compound and method for producing the same, and method for producing hydrogen-phosphine-borane compound
12/25/2012US8338390 Multifunctional and biologically active matrices from multicomponent polymeric solutions
12/25/2012US8338389 Agent for preventing or ameliorating obesity
12/25/2012US8338388 Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained
12/25/2012US8338387 Small molecule stimulators of neuronal growth
12/25/2012US8338386 Prevention/treatment of ichthyosis vulgaris, atopy and other disorders
12/25/2012US8338385 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/25/2012US8338383 Use of immunomodulators for the treatment of cancer
12/25/2012US8338382 Method of treating impaired mitochondrial function
12/25/2012US8338381 Composition and method for the treatment of eye disease
12/25/2012US8338367 Fused heteroaryl diamide compounds useful as MMP-13 inhibitors
12/25/2012US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
12/25/2012US8338362 Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
12/25/2012US8338338 Formulations comprising triazoles and alkoxylated amines
12/25/2012US8338180 Using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds
12/25/2012US8338150 Method for combined parallel agent delivery and electroporation for cell structures an use thereof
12/25/2012US8338141 Culturing a methionine-producing microorganism in a fermentation medium to yield a fermentation broth; solubilizing methionine by raising temperature of the broth, removing insoluble material from fermentation broth to yield a methionine preparation, adding acid and base into the broth
12/25/2012US8338125 Kit for measuring nitric oxide synthase activity
12/25/2012US8338087 Composition and process for post-etch removal of photoresist and/or sacrificial anti-reflective material deposited on a substrate
12/25/2012US8337917 Nut skin products
12/25/2012US8337906 Nasal composition
12/25/2012US8337899 Solid pharmaceutical dispersions with enhanced bioavailability
12/25/2012US8337891 Enteric coated composition comprising prostaglandin analogs as chloride channel opener
12/25/2012US8337887 Rapidly disintegrating taste-masked tablet
12/25/2012US8337886 Pellet formulation for the treatment of the intestinal tract
12/25/2012US8337884 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/25/2012US8337883 Transdermal delivery systems
12/25/2012US8337881 For use as wound closure adhesives
12/25/2012US8337877 Reduction of infection associated with medical device
12/25/2012US8337873 Having hollow core, porosity on side walls, and comprising a biocompatible material that contains an encapsulated biological or chemical agent loaded in core, released by controlled release technology temporally and spatially, accelerating tooth or bone healing
12/25/2012US8337872 Method of inhibiting the transmission of influenza virus
12/25/2012US8337871 Insecticide formulation
12/25/2012US8337870 Low toxicity topical active agent delivery system
12/25/2012US8337869 Analgesic cream
12/25/2012US8337863 Anti-sepsis conjugate vaccine
12/25/2012US8337861 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
12/25/2012US8337835 Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337824 Linear polyol stabilized polyfluoroacrylate compositions
12/25/2012US8337823 Modified macromolecule
12/25/2012US8337819 Pharmaceutical composition for the oral hygiene, the treatment of the periodontal illnesses and the halitosis
12/25/2012US8337817 Preparation for transnasal application
12/25/2012US8337816 Comprising inhalable medicament particles having a mass median aerodynamic diameter no greater than 10 mu m and 50% of a non-respirable excipient fraction comprising low density excipient particles having an aerodynamic diameter greater than 10 mu m and a geometric diameter greater than 30 mu m
12/25/2012US8337482 System for perfusion management
12/20/2012WO2012174555A2 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012WO2012174552A2 Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system
12/20/2012WO2012174549A2 Blockade of eosinophil production by toll-like receptors
12/20/2012WO2012174537A2 Small molecule screening for mouse satellite cell proliferation
12/20/2012WO2012174522A1 Combined chemical modification of sphingosine-1-phosphate (s1p) and cxcr4 signalling pathways for hematopoietic stem cell (hsc) mobilization and engraftment
12/20/2012WO2012174511A1 2-methylthiopyrrolidines and their use for modulating bacterial quorum sensing
12/20/2012WO2012174488A2 Agents and methods for treating ischemic and other diseases
12/20/2012WO2012174476A2 Antisense modulation of fibroblast growth factor receptor 4 expression
12/20/2012WO2012174470A1 Antisense modulation of pyruvate carboxylase expression
12/20/2012WO2012174436A1 Nuclear receptor modulators and their use for the treatment and prevention of cancer
12/20/2012WO2012174379A2 Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using
12/20/2012WO2012174362A1 Pyrazole derivatives as cannabinoid receptor 1 antagonists
12/20/2012WO2012174342A1 Trpv4 antagonists
12/20/2012WO2012174340A1 Trpv4 antagonists
12/20/2012WO2012174327A1 Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab
12/20/2012WO2012174312A2 Benzimidazole derivatives as antiviral agents
12/20/2012WO2012174286A1 Catechol derivatives for treatment of oxidative stress diseases
12/20/2012WO2012174262A2 Formulations and methods of treating subjects having central nervous system, endocrine, inflammatory or cardiovascular disorders or at-risk thereof with highly purified omega-3 fatty acid formulations
12/20/2012WO2012174253A1 Methods for aloe processing
12/20/2012WO2012174243A1 D -serine for the treatment of visual system disorders
12/20/2012WO2012174229A2 Methods for the synthesis and purification of deoxycholic acid
12/20/2012WO2012174164A2 Agonists of gpr131 and uses thereof
12/20/2012WO2012174158A2 Administration of benzodiazepine
12/20/2012WO2012174154A1 Modulation of inflammatory responses by factor vii
12/20/2012WO2012174126A1 METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY
12/20/2012WO2012174095A1 3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
12/20/2012WO2012174082A1 Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
12/20/2012WO2012174061A1 Combination of panobinostat and ruxolitinib in the treatment of cancer such as a myeloproliferative neoplasm
12/20/2012WO2012174055A1 Wound healing using complement inhibitors
12/20/2012WO2012174049A2 Compositions and methods for controlling neuronal excitation
12/20/2012WO2012174035A2 A nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
12/20/2012WO2012174013A2 Treatment of cardiovascular disease, stroke, and inflammatory conditions
12/20/2012WO2012173987A2 Methods of treatment using a bcat1 inhibitor
12/20/2012WO2012173952A1 Piperazine derivatives, compositions, and uses related thereto
12/20/2012WO2012173917A1 Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment
12/20/2012WO2012173850A1 Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mglu2 receptor agonist
1 ... 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 ... 7860